Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/12/2008EP1990057A1 Beta-secretase substrates and uses thereof
11/12/2008EP1990056A1 Tooth root formation promoter and method for promotion of tooth root formation
11/12/2008EP1990048A2 Therapy of benign prostatic hyperplasia (bph)
11/12/2008EP1990040A1 Nanoparticle delivery vehicle
11/12/2008EP1989328A2 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
11/12/2008EP1989308A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases
11/12/2008EP1989304A1 A method of removing a non-metallic protein inhibitor from a liquid pharmaceutical preparation
11/12/2008EP1989289A2 Methods and compositions for repair of cartilage using an in vivo bioreactor
11/12/2008EP1989228A2 Metallothionein-derived peptide fragments
11/12/2008EP1989224A2 Immunogenic peptides and methods of use
11/12/2008EP1988927A2 Engineered antibody-stress protein fusions
11/12/2008EP1988923A1 Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist
11/12/2008EP1988917A2 Compositions and methods to enhance viability and function of islet cells
11/12/2008EP1988916A1 Methods and agents for reducing oxidative stress
11/12/2008EP1988915A1 A method of modulating cellular activity and agents for use therein
11/12/2008EP1988914A1 Combination of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes
11/12/2008EP1988913A1 G-csf liquid formulation
11/12/2008EP1988911A2 Compositions and methods for transport of molecules with enhanced release properties across biological barriers
11/12/2008EP1988910A2 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
11/12/2008EP1988882A2 Prolongation of survival of an allograft by inhibiting complement activity
11/12/2008EP1988853A2 Bone graft materials derived from mineralized gelatin
11/12/2008EP1950222A9 Method for detecting antibodies in body fluids via an immune reaction with glycoprotein 2 (GP2) from zymogen granula of the pancreas for a differential diagnosis of inflammatory bowel diseases and chronic pancreatitis
11/12/2008EP1799709A4 Myostatin isoform
11/12/2008EP1587484A4 Method of treating angiogenic tissue growth
11/12/2008EP1523582B1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1472278B1 Macrocyclic peptides active against the hepatitis c virus
11/12/2008EP1465912B1 Chimeric tnf ligands
11/12/2008EP1444349B1 Polypeptides of moraxella (branhamella) catarrhalis
11/12/2008EP1436321B9 Synthesis of cyclosporin analogs
11/12/2008EP1432729B1 Peyers's patch and/or m-cell targeting ligands
11/12/2008EP1424894B1 Inhibition of pathological angiogenesis in vivo
11/12/2008EP1423154B1 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments
11/12/2008EP1404305B1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient
11/12/2008EP1395275B1 Beta-secretase substrate and uses thereof
11/12/2008EP1231935B1 Attenuation of angiogenesis by use of chondroitin sulfate degrading enzymes
11/12/2008EP1083930B1 Insulin supplemented infant formula
11/12/2008EP0950103B1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
11/12/2008EP0944647B1 Submucosa extracts
11/12/2008EP0850313B1 Improved aav vectors for gene therapy
11/12/2008EP0792359B1 Transcription factor e2f-4
11/12/2008EP0750668B1 Novel muteins of ifn-beta
11/12/2008EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
11/12/2008CN101305092A Protein kinase c peptide modulators of angiogenesis
11/12/2008CN101305017A Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
11/12/2008CN101304762A Compositions and methods for treating or preventing flaviviridae infections
11/12/2008CN101304759A Vaccines using pattern recognition receptor-ligand:lipid complexes
11/12/2008CN101304758A Recombinant interferon Alpha2 (IFNAlpha2) mutants
11/12/2008CN101304757A Compositions and methods for less immunogenic pr0tein-lip1d complexes
11/12/2008CN101304727A Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302501A PEGylated uricoxidase compound, preparing method, preparation and use thereof
11/12/2008CN101302490A Method for reforming lidamycin-producing bacteria by means of gene substitution technology
11/12/2008CN101302256A Novel recombinant fusion molecule and antineoplastic treatment function thereof
11/12/2008CN101302252A Extrasin alphal (Tal) analogue, production process and medical use thereof
11/12/2008CN101302251A Cyanea-originated glucoprotein having immunopotentiation activity, preparation and use thereof
11/12/2008CN101302249A Self-assembly short peptide and use thereof in antineoplastic medicine preparation
11/12/2008CN101302246A Melanin cortical hormone receptor heptapeptide excitant, preparation and use thereof
11/12/2008CN101302245A Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN101301490A Method for preparing medical level type II collagen
11/12/2008CN101301475A Peg化因子vii糖型 Peg factor vii sugar type
11/12/2008CN101301474A Artificial cell enzyme and preparation thereof
11/12/2008CN101301468A Uses of leukaemia inhibition factor
11/12/2008CN101301467A Uses of BMP-7 in preparing medicament for preventing and/or treating liver fibrosis
11/12/2008CN101301466A Medicament for treating AIDS
11/12/2008CN101301465A Fowl transfer factor nano liposomes and preparation thereof
11/12/2008CN101301329A Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof
11/12/2008CN101301309A Further novel forms of interfering RNA molecules
11/12/2008CN101301274A Compound mequindox soluble powder for animals and preparation thereof
11/12/2008CN100432229C Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
11/12/2008CN100432107C Protein for promoting erythrocyte growth factor activity and its use
11/12/2008CN100432103C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells.
11/12/2008CN100432102C Blood platelet reinforcing protein and application thereof
11/12/2008CN100432099C Transcription factor
11/12/2008CN100432096C Transfer factor specific for SARS virus and method for preparing same
11/12/2008CN100431613C Two kinds of novel angiogenesis-inhibiting medicine and its uses in preventing and treating tumour
11/12/2008CN100431604C C1 inhibitor with short half-life for transient treatment
11/12/2008CN100431603C Medicine for preventing and treating bee toxicosis from picking camellia and method
11/12/2008CN100431602C Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
11/12/2008CN100431601C Cyclosporine microball preparation for treating endophthalmitis
11/12/2008CN100431600C Pharmaceutical compositions
11/12/2008CN100431599C Brain protein hydrolysate and production process of its freeze dried preparation
11/12/2008CN100431419C Biological agent for foot disinfection
11/11/2008US7449563 Methods and compositions for destabilizing microtubules
11/11/2008US7449560 Phosophoinositoglycan binding proteins
11/11/2008US7449559 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states
11/11/2008US7449554 Antibodies against the PRO4977 polypeptides
11/11/2008US7449548 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
11/11/2008US7449546 Dissolving a predetermined quantity of reduced glutathione in an aqueous medium having a pH of between 5.0 and 8.0 to produce a reduced glutathione solution having a predetermined initial concentration; storing solutions of reduced glutathione without allowing oxidation of the glutathione to a disulfides
11/11/2008US7449545 Antimicrobial bolisin peptides
11/11/2008US7449544 Inhibiting cyclin dependent kinase 2/cyclin complexes
11/11/2008US7449543 Binds to the polypeptide g34872 or binds to a calcium/calmodulin-dependent kinase II; treatment or diagnosis of central nervous system and bipolar disorders
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/11/2008US7449447 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/11/2008US7449445 Conductive peptide nanofiber and method of manufacture of the same
11/11/2008US7449444 Hydroxyethyl starch-containing polypeptide compositions
1 ... 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 ... 3163